$WKCMF

Wacker Chemie AG reported mixed Q4 2025 earnings, with revenues showing a decline while adjusted earnings met analysts' expectations. The company faces challenges due to rising raw material costs and market competition but is optimistic about future demand in the semiconductor and biotech industries. Management highlighted strategic initiatives aimed at cost efficiencies that could improve margins. Analysts remain cautious about short-term volatility while acknowledging the long-term growth potential in key sectors. Investor sentiment appears mixed, reflecting both concern and optimism regarding Wacker Chemie's outlook.